$20.18
+0.03 (+0.15%)
NOV News30 articles
SLB Shares Decline Amid Oil Price Drop Despite Indonesian Gas Contract
SLB shares dropped 1.8% to $50.64 as oil prices declined, overshadowing new offshore drilling contracts for a deepwater gas project in Indonesia targeting first production by 2028.
Novo Nordisk Shares Plunge 8% as Investors Question Post-Semaglutide Growth Strategy
Novo Nordisk ADRs dropped 8.18% to $39.705 after its capital markets day, as investors questioned how it will offset the 2032 U.S. semaglutide patent expiry. The company targets over DKK 150B in pipeline sales by 2035.
Novo Nordisk Shares Drop 5% as 2030 Strategy Omits Growth Target
Novo Nordisk shares slid 5% after its 2030 strategy omitted a numeric growth target, focusing instead on pipeline diversification and launches.
Lenovo Stock Pulls Back 4.7% After Record Rally, AI Server Margins in Focus
Lenovo shares dropped 4.7% on Monday after a record-setting rally, raising questions about AI-server margin sustainability. The stock remains 14.7% above its September 15 close.
Novo Nordisk Faces Semaglutide Test at Capital Markets Day
Novo Nordisk's Capital Markets Day on Monday will test its strategy as semaglutide dominates sales. Stock closed at $43.24, with analysts split on valuation.
Mitsuoka LA1 Roadster Set for Nov. 26 Debut; Mazda MX-5 Link Still Unverified
Mitsuoka will unveil its retro-styled LA1 roadster on Nov. 26, but has not confirmed speculation that it uses a Mazda MX-5 Miata platform. The niche model's impact on Mazda's financials is expected to be minimal.
Tariff Documents Reveal Cost Pressures on Airbus and Novelis Alabama Projects
Emails reveal tariff costs threatening Airbus and Novelis Alabama projects. Novelis reports $143M EBITDA impact; Airbus expands Mobile despite challenges.
Kennedy Center Main Building to Close for Two-Year $257M Renovation
The Kennedy Center will close its main building for two years starting immediately, using $256.657 million in federal funds, while facing a projected $23 million operating shortfall.
Enova's Grasshopper Deal Collapse Wipes Out $1.37B in Market Value
Enova's decision to abandon its Grasshopper Bancorp acquisition erased $1.37 billion in market value, with shares plunging 24% as investors question the company's strategic direction.
Veea Soars 158% on NovaGen Deal, But Valuation Terms Remain Unclear
Veea shares jumped 158% on news of a proposed merger with NovaGen Group, yet the $750 million valuation lacks critical deal terms, leaving investors without a clear target price.
Kennedy Center Faces Cash Crunch Amid $257M Renovation Fund
The Kennedy Center's board weighs crisis resolutions amid a $257M repair fund, raising questions about liquidity and governance.
GE Vernova's Investor Conference: Key Test for 125 GW Gas Target
GE Vernova CEO Scott Strazik addresses investors Wednesday, with the company's 125 GW gas equipment goal under scrutiny. Conversion rates, cash flow, and wind losses are key watch points.
Amex Innovation Ranking: Why Investors Should Focus on Data, Not Awards
American Express' No. 3 innovation ranking highlights its data platforms, but investors should focus on expense trends and ROI from initiatives like Lumi and Passport.
Nova Scotia's New Utility Review Could Reshape Emera's Profit Model
Nova Scotia opens a review that could tie Nova Scotia Power's profits to performance metrics, altering Emera's regulatory outlook. No immediate financial impact, but long-term risk for EMA shareholders.
Novig's $500M Valuation: Why Public Investors Can't Buy In Yet
Novig's $500 million valuation and CFTC approval make headlines, but the company remains private. Public investors can track event-contract competition via HOOD, DKNG, and FLUT.
Novartis Shares Plunge 9% as Key Drug Trial Misses Goal
Novartis shares tumbled 9% after its lead Avidity drug failed a pivotal trial, erasing about $22 billion in value and raising doubts about its pipeline.
GE Vernova T&D India Soars 6.5% on L1 Bid for Power Grid's HVDC Project
GE Vernova T&D India shares surged 6.5% after Power Grid named it the lowest bidder for a 6,000 MW HVDC project, but the contract value remains undisclosed.
Novartis Surges on MS Drug Data, $3B Peak Sales Forecast
Novartis (NVS) shares jumped 5.6% after Phase III trials for remibrutinib in multiple sclerosis met primary endpoints, with BofA projecting $3B peak sales. Full data due Oct 21-23.
Novartis Jumps 6% on Remibrutinib Data as Patent Cliff Looms
Novartis ADRs jumped 6% after remibrutinib met Phase III endpoints in multiple sclerosis, easing concerns about patent expirations. Stock hit $161.22.
Novavax Dips Slightly After Nuvaxovid Gains Approval in US, EU, Japan
Novavax shares slipped 0.6% to $9.00 after regulatory approvals for its updated vaccine in the US, EU, and Japan. The company now relies on partners like Sanofi for commercialization, with royalties expected but not yet in guidance.
PepsiCo's Mountain Dew Trolli Launch Tests Innovation Amid Volume Dip
PepsiCo expands its Mountain Dew Trolli collaboration with new flavors and distribution, aiming to counter a 4% beverage volume decline. The stock remains below analyst targets.
Novo Nordisk Gains 1.9% as Medicare Wegovy Copay Trial Raises Pricing Questions
Novo Nordisk's ADR gained 1.85% to $45.71 as Medicare's GLP-1 Bridge offers Wegovy at $50 monthly, but analysts see limited upside with all Holds.
Drone Escalation Strains Russian Fuel Market as Novorossiysk Port Reopens
Drone attacks are squeezing Russia's fuel market even as Novorossiysk resumes crude exports. Refining capacity has fallen to near two-decade lows, boosting diesel margins and refiner stocks.
Novo Nordisk Outlook Upgrade Fails to Lift Shares as Analysts See Slim Gains
Novo Nordisk stock slipped 2.9% last week even after management raised its 2026 guidance. Analysts see only 2.2% upside, with most rating the stock a Hold.
Dell Shares Surge as Lenovo's AI Results Signal Robust Server Demand
Dell (DELL) gains 4% premarket as Lenovo's AI revenue surge confirms strong server demand, with shares trading above the average analyst target.
Space Innovators ETF Surges 18% as SpaceX Rally Boosts Portfolio
Tema Space Innovators ETF (NASA) gained 18.2% last week, outperforming peers, as SpaceX shares surged and investors await earnings from Rocket Lab and AST SpaceMobile.
Paranovus Rockets 119% on $33M Heyviva Deal, Market Cap Dwarfed
PAVS stock jumped over 119% premarket after a $33M Heyviva asset purchase, which is 7.8 times its Wednesday market cap. The deal raises questions about valuation and financing.
Novo Nordisk Slips 4% as Profit Beat Fails to Quell Wegovy Worries
Novo Nordisk shares dropped 4% in Copenhagen after Q2 profit beat estimates, but concerns over Wegovy and pipeline setbacks weighed on sentiment.
Novo Nordisk ADR Slides Despite Strong Q2, Danish Shares Await Catch-Up
Novo Nordisk's ADR dropped 6.8% despite Q2 earnings surpassing forecasts, as investors weigh pipeline impairments and competitive pressures.
Novo Nordisk Shares Plunge 9% as ZEUS Trial Fails to Show Cardiovascular Benefit
Novo Nordisk shares fell sharply after ZEUS trial data showed no significant cardiovascular benefit, wiping out $20.5 billion in market cap and underscoring heavy reliance on GLP-1 franchise.